PII-LBA2 VALIDATION OF A NOVEL NON-INVASIVE URINE EXOSOME GENE EXPRESSION ASSAY TO PREDICT HIGH-GRADE PROSTATE CANCER IN PATIENTS UNDERGOING INITIAL BIOPSY WITH AN EQUIVOCAL PSA. | Zendy

James M. McKiernan | Zendy; Michael Donovan | Zendy; Vince O’Neill | Zendy; Stefan Bentink | Zendy; Mikkel Noerholm | Zendy; Susan Belzer | Zendy; Johan Skog | Zendy; Alan W. Partin | Zendy; Gerald L. Andriole | Zendy; Gordon Brown | Zendy; James S. Cochran | Zendy; John T. Wei | Zendy; Ian M. Thompson | Zendy; Peter Carroll | Zendy

Open Access

PII-LBA2 VALIDATION OF A NOVEL NON-INVASIVE URINE EXOSOME GENE EXPRESSION ASSAY TO PREDICT HIGH-GRADE PROSTATE CANCER IN PATIENTS UNDERGOING INITIAL BIOPSY WITH AN EQUIVOCAL PSA.

Author(s) -

James M. McKiernan,

Michael Donovan,

Vince O’Neill,

Stefan Bentink,

Mikkel Noerholm,

Susan Belzer,

Johan Skog,

Alan W. Partin,

Gerald L. Andriole,

Gordon Brown,

James S. Cochran,

John T. Wei,

Ian M. Thompson,

Peter Carroll

Publication year - 2015

Publication title -

the journal of urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.402

H-Index - 256

eISSN - 1527-3792

pISSN - 0022-5347

DOI - 10.1016/j.juro.2015.03.082

Subject(s) - medicine , prostate cancer , interim , prostate biopsy , cancer , history , archaeology

Validation of a Novel Non-Invasive Urine Exosome Gene Expression assay to predict High-grade prostate cancer in patients undergoing initial biopsy with an equivocal PSA. James McKiernan*, Michael Donovan, NYC, NY, Vince O'Neill, Cambridge, MA, Stefan Bentink, Mikkel Noerholm, Martinsried, Germany, Susan Belzer, St. Paul, MN, Johan Skog, Cambridge, MA, Alan Partin, Baltimore, MD, Gerald Andriole, St. Louis, MO, Gordon Brown, Vorhees, NJ, James Cochran, Dallas, TX, John Wei, Livonia, MI, Ian Thompson, San Antonio, TX, Peter Carroll, San Francisco, CA

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research